Matt Andrusiak

Matt Andrusiak is a patent agent trainee in Gowling WLG’s Ottawa office, practising in the Intellectual Property Group. Matt works alongside patent agents in the bio group, assisting them with drafting and prosecuting applications in the areas of biotechnology, life sciences, microbiology, pharmaceutical and chemical formulations, diagnostics, and medical devices.

Matt’s diverse education and research background spans the fields of neuroscience, molecular biology, human disease, biotechnology, CRISPR/Cas9, disease therapeutics, gene therapy, developmental biology, vertebrate animal models, invertebrate models, and biochemistry.

Prior to joining Gowling WLG, Matt was a project scientist and postdoctoral fellow in the Neurobiology program at the University of California San Diego (UCSD). Matt’s research focused on understanding why sustaining traumatic brain injuries often leads to a neurological condition resembling Alzheimer’s disease. Matt’s postdoctoral work is published in highly regarded journals including Neuron, eLife and the Journal of Biological Chemistry.

In addition to his research at UCSD, Matt lectured at the undergraduate and graduate levels. He was also an active member of a teaching group focused on educating teaching assistants in the biology program on the importance of equity, diversity and inclusivity.

Before attending UCSD, Matt obtained a BSc (Biochemistry) and PhD (Cellular and Molecular Medicine) from the University of Ottawa. 

Career & Recognition

Filter timeline:
  • 2020

    • Education
      International Ambassador, UCSD
    • Community
      Postdoc Teaching Mentor Group, UCSD (Co-Founder)
    • Community
      The Inclusive Classroom, UCSD
    • Education
      University of California San Diego, Postdoctoral Fellowship
  • 2016

    • Rankings & Awards
      Canadian Institute of Health Research Postdoctoral Fellowship
  • 2014

    • Education
      Duke University Medical Center, Postdoctoral Fellowship
    • Rankings & Awards
      American Heart Association Postdoctoral Fellowship
  • 2013

    • Education
      University of Ottawa, PhD (Cellular and Molecular Medicine)
    • Education
      Let’s Talk Science, University of Ottawa
  • 2008

    • Education
      University of Ottawa, BSc (Biochemistry)

Selected Publications

Andrusiak MG, Jin Y. Multiple roles of RNA regulatory factors in neuronal development and function in C. elegans. The Oxford Handbook of Neuronal Protein Synthesis. Sep. 2020. doi: 10.1093/oxfordhb/9780190686307.013.26

Andrusiak MG, Sharifnia P, Lyu X, Dickey A, Wang Z, Wu Z, Chisholm AD, Jin Y. Inhibition of axon regeneration by liquid-like TIAR-2 granules. Neuron. 104, 1-15. 2019 Oct.13. doi: 10.1016/j.neuron.2019.07.004. ePub: Aug. 1, 2019

Kim KW, Tang NH, Piggott CA, Andrusiak MG, Park S, Kurup N, Cherra SJ III, Wu Z, Chisholm AD, Jin Y. Expanded genetic screening in C. elegans identifies new regulators of axon regeneration and an inhibitory role of NAD+. Elife. Nov. 21, 2018;7. pii: e39756.

Andrusiak MG, Jin Y. Context specificity of stress-activated mitogen-activated protein kinase signaling: the story as told by C. elegans. Journal of Biological Chemistry. Apr. 8, 2016; 291(15):7796-804.

Andrusiak MG, Vandenbosch R, Park DS, Slack RS. The retinoblastoma protein is essential to maintain survival of post-mitotic neurons. J Neurosci. Oct 17, 2012; 32(42):14809-14.

Selected Presentations

The molecular mechanisms driven by prion-like domain containing proteins. Queen’s University Department of Biology. Kingston, ON. Mar. 2020

The molecular mechanisms driven by prion-like domain containing proteins. University College London. London, UK. Feb. 2020

The molecular mechanisms driven by prion-like domain containing proteins. University of Utah Department of Neurobiology and Anatomy. Salt Lake City, UT. Jan. 2020

Brain injury and regeneration: Genetic insights. uOttawa Department of Biology. Ottawa, ON. May 2019

Inhibition of axon regeneration by liquid-like protein granules. American Society for Cell Biology. San Diego, CA. Dec. 2018

Axon injury alters the liquid-like properties of TIAR-2, an aggregation-prone inhibitor of axon regeneration. San Diego Biology Retreat. Lake Arrowhead, CA. Sep. 2017

Intrinsic inhibition of axon regeneration by the prion-like domain containing protein TIAR-2. International C. elegans Meeting. Los Angeles, CA. Jun. 2017

TIAR-2 is a novel inhibitor of axon regeneration. UCSD/Paralyzed Veterans of America Neural Regeneration Symposium. La Jolla, CA Oct. 2016

Differential roles for the retinoblastoma protein in cycling and quiescent neural populations. University of California, San Diego. La Jolla, CA. Jul. 2014

Differential roles for the retinoblastoma protein in cycling and quiescent neural populations. Neuroscience Seminar Series. University of Ottawa. Ottawa, ON. Apr. 2012